Objective
To achieve long-term capital growth by investing in biotechnology and other life sciences companies.
Management group
Schroder Investment Management
Launch date
06/05/1994
Domicile
United Kingdom
Fund manager
Ailsa Craig, Marek Poszepczynski
Dividend frequency
Semi-Annually
Wind-up provisions
The Association Articles of the company provide for Directors to put forward a proposal for the continuation of the company at the AGM at two-yearly intervals. The upcoming continuation vote is scheduled for the December 2023 AGM.
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
264.18 327.40 690.00 782.72 -11.85 4 4.09 Jul, Dec 1.4 (31/08/2023)
Scroll

Dividends

Dividends declared in last 12 months

Ex-Dividend date Payment date Dividend amount Dividend type Special dividend Financial year
21/12/2023 26/01/2024 13.900 Capital No 2024
27/07/2023 25/08/2023 14.200 Capital No 2023
Scroll

Performance (%)

Return type 1 year 3 years 5 years 10 years
International Biotechnology Share price total return 4.7 -0.2 37.2 188.4
Biotechnology & Healthcare AIC sector Share price total return -2.2 -20.5 -1.1 111.5
Scroll

Share structure

Number of shares
38,287,407

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 95,395 1,267,340 12,360,570 82,996,057
Average N/A 61,942 49,341 65,868
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 0.66 8.41 78.90 569.99
Average N/A 0.41 0.32 0.45
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GB0004559349 IBT GBX London Stock Exchange - MAIN
Scroll

Top holdings

Data as at : 31/12/2023

Investment % of total assets
Incyte Corp 6.6
Amgen Inc 5.8
Gilead Sciences Inc 5.6
Vera Therapeutics Inc Class A 5.0
Sv Fund Vi Investment 4.9
Intra-Cellular Therapies Inc 4.6
Supernus Pharmaceuticals Inc 4.6
Biomarin Pharmaceutical Inc 4.3
AstraZeneca PLC ADR 3.7
Scb Sholo211123b 20-Dec-2023 6.460000% 19-Jan-2024 -13.4

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.